You searched for "AMM"
What’s next in retinal imaging? Faster, deeper and full-on
Fast-evolving technological leaps are opening the way toward clinically useful ocular coherence angiography, generating 3-dimensional microvasculature maps without intravenous dye injection, as well as whole-eye imaging, handheld patient-operated optical coherence tomography (OCT) devices and, for challenging vitreoretinal procedures, integrated intraoperative...The College of Optometrists: Optometry Tomorrow 2024 (incorporating BCLA Focus)
28 April 2024
-29 April 2024
by Claire McLoughlin, PR Manager, College of Optometrists, UK. The College of Optometrists and British Contact Lens Association (BCLA) welcomed around 900 attendees at Optometry Tomorrow 24 – now incorporating BCLA Focus – on 28–29 April. This was the 20th...
Do patient demographics influence AMD clinic attendance during COVID-19 lockdown?
3 June 2021
| Kumarapaksha Mohottalage Bhagya Mekhalani Weerasinghe, Jai Shankar
|
EYE - Vitreo-Retinal
The authors assess the impact of the COVID-19 pandemic on adherence to scheduled clinic appointments among age-related macular degeneration patients in a clinic in North Wales. The COVID-19 pandemic has significantly affected the population, affecting economic and social wellbeing, whilst...
5-FU vs. Avastin as adjunct to conjunctival autograft
The authors compare the outcome of pterygium treatment using 5-fluorouracil as an adjunct to free conjunctival autograft versus bevacizumab (Avastin) as an adjunct to free conjunctival autograft, via a randomised controlled prospective study. Seventy eyes of 70 patients were included...Association between neurodegeneration and macular perfusion in the progression of diabetic retinopathy
9 August 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Diabetes, Neurodegeneration, Progression, Retinopathy, Vessel closure
In this prospective three-year longitudinal study, the authors aimed to explore the relation between retinal neurodegenerative changes and vessel closure (VC) in individuals with non-proliferative diabetic retinopathy (NPDR). The participants included 74 individuals with type 2 diabetes, NPDR, and Early...
Update on emerging therapies for age-related macular degeneration
4 December 2023
| Rod McNeil
|
EYE - Vitreo-Retinal
The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...
What's trending Apr/May 2022
5 April 2022
| Stephanie Chiu
|
EYE - General
A round-up of the eye-related hot topics that have been trending over the last few weeks. #ArgusI #ArgusII #bioniceye #retinitispigmentosa #SecondSight Remember Argus I & Argus II? Its star burned bright, touted as the future of treatment for retinitis pigmentosa....
SILMO 2019: Anything goes, but sustainability grows
29 October 2019
Trying to spot the trends at this year’s SILMO in Paris, one of the largest optical fairs in the world, was a tough ask. Thin metals, especially in rose gold, abounded, but that’s now; tomorrow remained elusive.
Eye News to partner with AOP Young Ophthalmologists Program
25 August 2021
We are delighted to announce our partnership with the AOP (Advanced Ophthalmologic Practice) Academy Young Ophthalmologists event 'Retina: How to avoid false friends'.
The International AMD Genomics Consortium study: another success in understanding the complex genetics of AMD
1 April 2017
| Valentina Cipriani
|
EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is a neurodegenerative complex disease of the eye and a major cause of blindness and visual impairment among the elderly worldwide. The early stages of the disease are characterised by asymptomatic pigmentary abnormalities and accumulation of...
Importing iron to the retina
1 October 2017
| Graham Wallace
|
EYE - Vitreo-Retinal
In the retina, iron is particularly critical for the visual phototransduction cascade. In the retinal pigment epithelium (RPE), RPE65 activity leads to 11-cis-retinaldehyde, the photosensitive component of rhodopsin production and iron containing enzymes are necessary for disc replacement in photoreceptor...
Detection of antiranibizumab antibodies in exudative AMD
1 December 2014
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this study the authors aimed to detect immune response to ranibizumab treatment in wet age-related macular degeneration (AMD). An ELISA was employed to quantify the anti-ranibizumab titre which was compared against the control anti-abciximab titre. Titres of anti-ranibizumab antibodies...